Product Information
CLARITHROMYCIN 250 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.3939 per EA under NDC 00527193106. Its NADAC has been published 513 times since Nov 2, 2016.
FDA first approved this application on Sep 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Lannett Company Inc.NDC
00527193106
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLARITHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA203584FDA Approved
9/28/2015
TE Code
AB
On Market Since
11/23/2019
Pharmacological Classes
Price Statistics
The NADAC for CLARITHROMYCIN 250 MG TABLET has been published 513 times since Nov 2, 2016, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3939 per EA |
|---|---|
| All-time high | $2.2022 (Nov 16, 2016) |
| All-time low | $0.3332 (Nov 20, 2024) |
| 52-week high | $0.5102 |
| 52-week low | $0.3421 |
| Median price | $0.5468 |
| Average price | $0.6234 |
| Largest weekly change | +73.4% (Jan 18, 2023) |
| Weeks tracked | 513 |
| Tracking since | Nov 2, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clarithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN 250 MG TABLET, manufactured by Lannett Company Inc., is $0.3939 per EA (NDC 00527193106), effective Sep 30, 2026.
How has the price of CLARITHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLARITHROMYCIN 250 MG TABLET has declined 82.1%. It has been tracked across 513 weekly CMS publications since Nov 2, 2016.
What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN 250 MG TABLET?
Since Nov 2, 2016, the NADAC for CLARITHROMYCIN 250 MG TABLET has ranged from a low of $0.3332 (Nov 20, 2024) to a high of $2.2022 (Nov 16, 2016), with a median of $0.5468 per EA.
Are there cheaper alternatives to CLARITHROMYCIN 250 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLARITHROMYCIN 250 MG TABLET, is $0.3707 per EA — about 6% below CLARITHROMYCIN 250 MG TABLET.
Who manufactures CLARITHROMYCIN 250 MG TABLET?
CLARITHROMYCIN 250 MG TABLET (NDC 00527193106) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.